Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $948 | $1,212 | $1,212 |
| - Cash | $490 | $230 | $4 |
| + Debt | $1 | $1 | $0 |
| Enterprise Value | $459 | $982 | $1,208 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| EBITDA | -$82 | -$40 | -$38 |
| % Margin | – | – | – |
| Net Income | -$68 | -$52 | -$38 |
| % Margin | – | – | – |
| EPS Diluted | -1.25 | -1 | -0.73 |
| % Growth | -25% | -37% | – |
| Operating Cash Flow | -$75 | -$46 | -$32 |
| Capital Expenditures | -$0 | -$1 | -$0 |
| Free Cash Flow | -$75 | -$46 | -$32 |